Carbaldrate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 15:20, 6 April 2020 (added FDA UNII to drug box). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Carbaldrate
Clinical data
Trade namesBasaljel
ATC code
Identifiers
CAS Number
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula(HO)2Al(CO3)Na·nH2O
3D model (JSmol)
  • C(=O)([O-])[O-].O.[OH-].[OH-].[Na+].[Al+3]
  • InChI=1S/CH2O3.Al.Na.3H2O/c2-1(3)4;;;;;/h(H2,2,3,4);;;3*1H2/q;+3;+1;;;/p-4
  • Key:YJTPLMXDQANDKS-UHFFFAOYSA-J
  (verify)

Carbaldrate (dihydroxyaluminum sodium carbonate) is an antacid.[1][2]

References

  1. ^ Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M (March 2000). "Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements". Pharmacol. Toxicol. 86 (3): 135–9. doi:10.1034/j.1600-0773.2000.d01-25.x. PMID 10752672.
  2. ^ "Dihydroxyaluminum Sodium Carbonate". drugs.com.


Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Carbaldrate&oldid=949451242"